Company intelligence / Profile preview

Pfützner Science & Health Institute

Mainz, Rhineland-Palatinate, Germany

Ownership: Private
Development stage: Other

Overview

Personalized diabetes treatment focused on advanced diagnostics, genetic and phenotypic analyses, individualized therapy plans, and early intervention using modern therapeutics. The institute has completed over 400 clinical studies, and its approach emphasizes early insulin use, risk minimization, and prevention of long-term complications in type 2 diabetes

Therapeutic areas: CardiovascularEndocrinology
Modalities: Small moleculeBiologicDeviceDiagnostics
Industry: Academic Hospital/University/Research

Partnerships

Lifecare AS (device/diagnostics R&D for diabetes, including Sencell project/technology; laboratory subsidiary acquired by Lifecare)

Beyond the preview

Go deeper on Pfützner Science & Health Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pfützner Science & Health Institute.

Explore the full profile